News

Erythromycin in babies and infants has been associated with an increased risk of infantile hypertrophic pyloric stenosis.

Experts from 13 national bodies, including seven Royal Colleges, have joined forces to launch new practical guidance to support doctors and other health professionals around valproate use in women and girls in their reproductive years.

This guidance, updated in December 2020 and endorsed by RCPCH, has been produced to inform all healthcare professionals of best practice around the use and prescribing of valproate. It supports them to navigate situations that could arise as a result of prescribing valproate to women during childbea...

After a successful RCPCH Conference Online 2020, we’re busy planning the 2021 event - and you are invited to get involved. We will be releasing full event details, including dates, over the coming weeks. In the meantime, the Conference Organising Committee is now inviting submissions of papers for ...

The Epilepsy12 Youth Advocates have been selected as joint winners in the HQIP Audit Heroes Awards 2020 in the Volunteer of the Year Category, recognising their hard work to support improvements in epilepsy care.

We’ve made innovative adaptations to keep Paediatric diabetes on the radar during the COVID-19 pandemic to improve care and outcomes.

Dr Yincent Tse is Lead for Patient Safety and Quality Improvement on the RCPCH Quality Improvement Committee and joint RCPCH/NPPG Medicines Committee. He recently completed his term as Secretary for the British Association for Paediatric Nephrology, and Deputy Head of School for North East and North...

Dr Colin Dunkley, Consultant Paediatrician and Clinical Lead for Epilepsy12 tells us about the recent report on the clinical and organisational aspects of epilepsies care for children and young people in England and Wales.

Two new reports have been released outlining the findings of a snapshot survey of the UK's general paediatric and neonatal services and workforce in September 2019. The reports provide a pre-COVID benchmark and give recommendations to government, service planners and other decision makers about how ...

Following recent publication of the REMAP-CAP trial for hydrocortisone and a meta-analysis of corticosteroids, the World Health Organization (WHO) has recently issued new interim guidance recommending the use of systemic corticosteroids in severe and critical COVID-19 disease.